Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Moodys
McKesson
AstraZeneca
Mallinckrodt

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Litigation Details for PDL BIOPHARMA, INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED (D.N.J. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in PDL BIOPHARMA, INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for PDL BIOPHARMA, INC. v. SUN PHARMACEUTICAL INDUSTRIES LIMITED (D.N.J. )

Date Filed Document No. Description Snippet Link To Document
2008-12-29 182 United States Patent No 3,985,758 (“the "/'58 patent”), United States Patent No. 4,711,902 (…the claims of the patent-in-suit - United States Patent No. 5,] 64,405 (“the ‘405 patent”). Because of the…lawsuit is a civil action for patent infringement arising under the patent laws of the United States, including…United States Patent and rl`rademark Office (“USPTO”), including the standards for patentability, and the …false statements to the Patent Office during the prosecution of the ‘405 patent. These statements are wholly External link to document
2009-03-31 190 Ltd. (―Sun‖) for infringement of patent 5,164,405 (―the ‗405 patent‖), of which the commercial embodiment…sufficient water to make up 1 ml volume. U.S. Patent No. 5,164,405 (claims section). B. Sun’s…such patent has expired; (III) the date on which such patent expires; or (IV) that such patent is invalid…pertinent patent. Thus, the ANDA applicant may be sued for patent infringement once the patent holder … of patent claims.‖). A. The ‘405 Patent’s Claims at Issue The ‗405 patent contains External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKinsey
Dow
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.